National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies

Page 11 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy AdultsCompletedNCT01931176Phase 1
• Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South AfricaWithdrawnNCT01927835Phase 1
• Leprosy Skin Test Antigens Phase 1CompletedNCT01920750Phase 1
• Study of the Complications Associated With Certain Stem Cell TransplantsCompletedNCT01919099
• Study of Antibiotic-induced Vaginal Yeast Infections in Healthy WomenTerminatedNCT01915251
• Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes InfectionCompletedNCT01915212Phase 1
• Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV MedicationsWithdrawnNCT01909414Phase 1
• Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and ChildrenCompletedNCT01893554Phase 1
• Effects of SQ109 on QTc Interval in Healthy SubjectsWithdrawnNCT01874314Phase 1
• Challenge Model for Assessment of Human TB ImmunityCompletedNCT01868464Phase 1
• Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking VaccineCompletedNCT01867463Phase 1
• Aerosolized and Intravenous Colistin in Healthy AdultsTerminatedNCT01863719Phase 1
• Collection of Biological Material From Pregnant Women in a Malarial RegionTerminatedNCT01862783
• Sildenafil for PNTM InfectionCompletedNCT01853540Phase 1/2
• Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and ChildrenCompletedNCT01852266Phase 1
• Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous DiseaseWithdrawnNCT01851460Phase 1
• Bone Marrow Stromal Cells for Inflammatory Bowel DiseasesTerminatedNCT01851343Phase 1
• Human Rhinovirus Infection and Airway Remodeling MediatorsTerminatedNCT01847768Not applicable
• Rituximab for Anti-cytokine Autoantibody-Associated DiseasesCompletedNCT01842386Phase 1
• Malaria Transmission Studies in MaliCompletedNCT01829737
• Sirolimus for Eosinophil-Associated Gastrointestinal DisordersTerminatedNCT01814059Phase 1
• Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463CompletedNCT01812889Phase 1
• Intranasal AD4-H5-VTN as an Adenovirus VaccineCompletedNCT01806909Phase 1
• Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected AdultsCompletedNCT01783977Phase 1
• Validation of Gene Expression Markers of Renal Allograft Functional DeclineCompletedNCT01782586
• Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months ApartCompletedNCT01782300Phase 1
• LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE VaccineCompletedNCT01751048Phase 1
• Testing the AVI-7100 Flu Drug in Healthy VolunteersCompletedNCT01747148Phase 1
• Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly PopulationsCompletedNCT01746082Phase 2
• RELIVE Informed Consent StudyCompletedNCT01742234
• Artemisinin-resistant Malaria in CambodiaCompletedNCT01736319
• Studying Cell Immune Responses to a Live Flu Vaccine in Healthy AdultsCompletedNCT01730144
• Genomics of Kidney TransplantationCompletedNCT01714440
• Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIVStatus unknownNCT01709448
• Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLEWithdrawnNCT01702038Phase 2
• Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 YearsCompletedNCT01676402Phase 1
• Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy VolunteersCompletedNCT01674218Phase 1
• Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus VaccinesCompletedNCT01674205Phase 1
• Fluorodeoxyglucose Imaging Studies to Detect LymphomaWithdrawnNCT01672918
• Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant RecipientsCompletedNCT01672164
• Clinical Outcomes of People Who Acquired HIV in Early LifeCompletedNCT01656564
• Influenza Antiviral DAS-181-F04 in Healthy AdultsCompletedNCT01651494Phase 1
• Gene Expression in HIV and Tuberculosis Co-infectionCompletedNCT01611402
• Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & AdolescentsCompletedNCT01609998Phase 1
• Volunteer Screening for Vaccine and Antivirals Clinical TrialsCompletedNCT01593709
• Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73CompletedNCT01592214Phase 1
• Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected AdultsCompletedNCT01578889Phase 1
• Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy AdultsCompletedNCT01574638Phase 1
• H5N1 Vaccination With and Without AS03: Systems Biology AnalysisCompletedNCT01573312Phase 1
• Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive AdultsCompletedNCT01571960Phase 1
• Determining Risk in Latent TuberculosisTerminatedNCT01571739
• Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or RifampinCompletedNCT01571414Phase 1
• Phase I Trial of a Single Dose of CRS3123CompletedNCT01551004Phase 1
• Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in UgandaCompletedNCT01549509Phase 1
• Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in UgandaCompletedNCT01549470Phase 1
• Effect of Filarial Infection on Immune Responses in Latent TuberculosisCompletedNCT01547884
• Sanaria™ PfSPZ Challenge VaccineCompletedNCT01546389Phase 1
• Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy AdultsCompletedNCT01534468Phase 1
• Live Lung Donor Cross-sectional Cohort StudyCompletedNCT01524835
• HIV Accelerated Liver Disease in UgandaCompletedNCT01524562
• Atopic Dermatitis Research Network (ADRN) Influenza Vaccine PilotCompletedNCT01518478Early Phase 1
• Phase 2a EBA Trial of AZD5847CompletedNCT01516203Phase 2
• Associating Renal Transplantation With the ITN Signature of ToleranceCompletedNCT01516177
• Apheresis to Obtain Plasma and White Blood Cells in MaliesWithdrawnNCT01511601
• Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus VaccineCompletedNCT01506570Phase 1
• Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV AloneCompletedNCT01498718Phase 1
• Registry for the Atopic Dermatitis Research NetworkCompletedNCT01494142
• Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant WomenWithdrawnNCT01490671Phase 2
• Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected AdultsCompletedNCT01479296Phase 1
• Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and ChildrenCompletedNCT01459198Phase 1
• Experimental AD4-H5-VTN Vaccine in Healthy VolunteersCompletedNCT01443936Phase 1
• Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza VaccineCompletedNCT01443663Phase 1
• Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant WomenWithdrawnNCT01443117Phase 2
• Experimental PfSPZ Vaccine in Adults Without MalariaCompletedNCT01441167Phase 1
• DAS181 in Patients With ParainfluenzaWithdrawnNCT01441024Phase 2
• Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected AdultsCompletedNCT01438606Phase 1
• SCH708980 With and Without AmBisome for Visceral LeishmaniasisWithdrawnNCT01437020Phase 1/2
• Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus VaccineCompletedNCT01436422Phase 1
• Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)CompletedNCT01434381Phase 1
• Interferon Responses in Eczema HerpeticumCompletedNCT01429311
• Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis CCompletedNCT01428700
• Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)CompletedNCT01423825Phase 1
• Immune Responses to Two Experimental HIV Vaccines in Healthy AdultsCompletedNCT01386489Phase 1
• Asthma Phenotypes in the Inner CityCompletedNCT01383941
• The Role of Epigenetics in Inner City AsthmaCompletedNCT01382836
• Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in MaliTerminatedNCT01381757
• Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult VolunteersCompletedNCT01381744Phase 1
• Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine StudyWithdrawnNCT01376765Phase 1
• Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical TrialsCompletedNCT01376726Phase 1
• Perceived Barriers to Patient Adherence After Pediatric Solid Organ TransplantationCompletedNCT01370746
• Extended Follow-Up After Islet Transplantation in T1DCompletedNCT01369082
• Preventing the Spread of Malaria in MaliCompletedNCT01360112
• Phase IC Study of Safety and PK of SQ109 300mg DailyCompletedNCT01358162Phase 1
• Phase 1 PK Study of XOMA 3ABCompletedNCT01357213Phase 1
• Patients Treated for SCID (1968-Present)Status unknownNCT01346150
• TMC207 +/- Rifabutin/RifampinCompletedNCT01341184Phase 1
• Study of Tolerant Kidney Transplant RecipientsCompletedNCT01338779
• Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3CompletedNCT01336699Phase 1
• Long-Term Effects of Sublingual Grass TherapyCompletedNCT01335139Phase 2
• Eosinophilic Esophagitis DatabankCompletedNCT01323803

← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas